Sonavi Labs

Sonavi Labs

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $6.6M

Overview

Sonavi Labs is a private, Baltimore-based digital health company founded in 2017, originating from a Gates Foundation challenge to reduce pediatric mortality from respiratory infections. The company has developed Feelix, an AI-powered digital stethoscope and software platform that allows for independent, at-home respiratory sound recording and analysis, targeting chronic disease management and remote patient monitoring. As a diagnostics company in early revenue stages, it aims to revolutionize respiratory care by decentralizing diagnosis and enabling proactive health management. Its growth is supported by strategic partners and a focus on universal design for broad accessibility.

Respiratory

Technology Platform

AI-powered digital auscultation platform combining a patient-friendly hardware device (digital stethoscope) with cloud-based software for automated respiratory sound analysis, trend monitoring, and secure data sharing.

Funding History

2
Total raised:$6.6M
Series A$5.4M
Seed$1.2M

Opportunities

The rapid growth of remote patient monitoring and telehealth creates a strong tailwind for at-home diagnostic tools.
There is also a significant unmet need in managing chronic respiratory diseases and in providing accessible diagnostic capabilities in low-resource settings globally.

Risk Factors

Key risks include navigating complex regulatory pathways and securing insurance reimbursement for the device and service.
Additionally, achieving clinical adoption requires robust validation and convincing healthcare providers to integrate patient-generated data into their workflows.

Competitive Landscape

The digital auscultation and respiratory remote monitoring space is competitive, with several established medtech companies and startups developing smart stethoscopes and AI analysis software. Sonavi Labs differentiates by focusing on a fully patient-driven, independent home-use model with an emphasis on universal design and affordability.